Polyunsaturated fatty acid supplementation for schizophrenia
Editorial Group: Cochrane Schizophrenia Group
Published Online: 19 JUL 2006
Assessed as up-to-date: 11 FEB 2009
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Irving CB, Mumby-Croft R, Joy LA. Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001257. DOI: 10.1002/14651858.CD001257.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 19 JUL 2006
This article has been cited by:
- 1Docosahexaenoic Acid, Inflammation, and Bacterial Dysbiosis in Relation to Periodontal Disease, Inflammatory Bowel Disease, and the Metabolic Syndrome, Nutrients, 2013, 5, 8, 3299, , , ,
- 4Neuroimaging and Treatment Evidence for Clinical Staging in Psychotic Disorders: From the At-Risk Mental State to Chronic Schizophrenia, Biological Psychiatry, 2011, 70, 7, 619, , , ,